Literature DB >> 20461908

INCAP studies of endemic goiter and its prevention.

Nevin S Scrimshaw1.   

Abstract

The high prevalence of goiter among adults in its member countries of Central America and Panama was observed as soon as INCAP began field studies. This led to systematic studies of goiter in schoolchildren in all of the countries as described, beginning with Guatemala where the rate was 38% nationally. However, efforts to eliminate the consequences of iodine with iodized salt using the water soluble potassium iodate and a process that had proved successful in Switzerland and the United States could not be used with the crude moist salt of the region. INCAP identified potassium iodate that is insoluble in water, and in four schools (two each in El Salvador and Guatemala) proved that the iodine in this compound was as available as that in potassium iodate. It remained evenly distributed in moist salt. When added to salt in Guatemala, goiter rate dropped to 15% in four years and less than 5% in eight years. Compulsory iodation of salt in other developing countries followed with comparable results. This method is now used in worldwide campaigns against iodine deficiency in developing countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461908     DOI: 10.1177/156482651003100111

Source DB:  PubMed          Journal:  Food Nutr Bull        ISSN: 0379-5721            Impact factor:   2.069


  3 in total

1.  Myxoedema in a patient with achondroplasia in rural area of Guatemala.

Authors:  Michel Juarez; Peter Rohloff
Journal:  BMJ Case Rep       Date:  2017-03-09

Review 2.  Cancer clusters in the USA: what do the last twenty years of state and federal investigations tell us?

Authors:  Michael Goodman; Joshua S Naiman; Dina Goodman; Judy S LaKind
Journal:  Crit Rev Toxicol       Date:  2012-04-21       Impact factor: 5.635

Review 3.  Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.

Authors:  Renata Ramalho; Martin Rao; Chao Zhang; Chiara Agrati; Giuseppe Ippolito; Fu-Sheng Wang; Alimuddin Zumla; Markus Maeurer
Journal:  Semin Immunopathol       Date:  2020-06-09       Impact factor: 9.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.